New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

45

Roche says updated data shows Tecentriq cocktail gives longer liver cancer survival

Roche presented updated data confirming the Swiss drugmaker’s immunotherapy Tecentriq, used in combination with Avastin, substantially improves overall survival in people with the most common form of liver cancer.

48

Covid-19 patients still have symptoms 6 months later

A roundup of scientific studies on the novel coronavirus and efforts to find treatments and vaccines includes research on Covid-19 patients who still have symptoms 6 months after falling ill.

50

RNAi-Focused Atalanta Therapeutics Launches

RNAi-focused Atalanta Therapeutics launched with $110 million in combined Series A funding and collaboration deals with Genentech and Biogen to address diseases related to the central nervous system, including Huntington’s, Alzheimer’s and Parkinson’s diseases.